...
机译:辛伐他汀和rho-激酶抑制剂Y-27632通过抑制YAP / TAZ核易位,预防PEYNIE的疾病衍生成纤维细胞中的肌纤维细胞转化
Laboratory of Experimental UrologyKU LeuvenLeuven Belgium;
Faculty of Health Education Medicine and Social CareAnglia Ruskin UniversityChelmsford UK;
Laboratory of Experimental UrologyKU LeuvenLeuven Belgium;
Department of Pediatric Nephrology and Growth and RegenerationUniversity Hospitals Leuven and KU;
Laboratory of Experimental UrologyKU LeuvenLeuven Belgium;
Laboratory of Experimental UrologyKU LeuvenLeuven Belgium;
Peyronie's disease; transforming growth factor‐β; Rho‐kinase inhibition; statins; Peyronies; Andrology;
机译:辛伐他汀和rho-激酶抑制剂Y-27632通过抑制YAP / TAZ核易位,预防PEYNIE的疾病衍生成纤维细胞中的肌纤维细胞转化
机译:人榫成纤维细胞介导的瘢痕形成的体外研究:Y-27632,rhO激酶抑制剂的作用
机译:rho-激酶抑制剂Y-27632通过阻断P38 MAPK和NF-κB途径在人牙龈细胞中阻断LPS诱导的IL-6和IL-8的生产
机译:辛伐他汀和岩石抑制剂Y-27632通过RhOA介导的ERK和P38信号传导途径抑制Graves的眼科衍生的眶下成纤维细胞的肌纤维细胞分化
机译:辛伐他汀和rho-激酶抑制剂Y-27632通过抑制YAP / TAZ核易位,预防PEYNIE的疾病衍生成纤维细胞中的肌纤维细胞转化